CIK 0000863894
- Non-accelerated filer
- Smaller reporting company
VERU INC.
Sign in to watch- Ticker
- VERU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- WI
- Entity type
- Operating
- EIN
- 391144397
- Phone
- +1 312-595-9123
- Business address
- 2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
- Former names
- FEMALE HEALTH CO
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 20,000 shares at an average $1.96 ($39,266)
- 4 Open-market buy Director bought 5,000 shares at $1.96 ($9,800)
- 4 Open-market buy Director bought 10,000 shares at $1.90 ($18,950)
- 4 Open-market buy Director bought 10,000 shares at $1.87 ($18,700)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.77 ($17,709)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.73 ($17,296)
- 4 Open-market buy Director bought 10,000 shares at $1.80 ($18,000)
- 4 Open-market buy Director bought 10,000 shares at $1.88 ($18,800)
- 4 Open-market buy President and CEO bought 10,000 shares at $1.82 ($18,200)
- 4 Open-market buy Director bought 25,000 shares at $1.75 ($43,650)
- 4 Open-market buy President and CEO bought 20,000 shares at $1.88 ($37,552)
- 4 Open-market buy Director bought 24,000 shares at $1.62 ($38,976)
- 4 Open-market buy President and CEO bought 20,000 shares at $1.67 ($33,438)
- 4 Open-market buy Director bought 20,000 shares at $1.52 ($30,328)
- 4 Open-market buy President and CEO bought 20,000 shares at $1.50 ($29,996)
- 3 Insider Initial Statement of Ownership
Page 10 of 30 · 594 filings